Non-specific blood components

Non-specific blood components refers to a heterogeneous group of blood constituents, primarily plasma proteins like albumin and alpha-1-acid glycoprotein, as well as cellular elements such as red blood cells (StatPearls, 2023). These components are not typically therapeutic targets; instead, they are fundamental to the pharmacokinetic behavior of almost all systemic drugs, acting as a reservoir that binds drugs non-specifically and influences the concentration of the free or pharmacologically active drug in the systemic circulation (PubMed, PMID: 11353112). For instance, albumin is the primary binder for acidic drugs, while alpha-1-acid glycoprotein typically binds basic drugs (NIH, 2022). Interactions with these components can lead to significant clinical consequences, particularly through displacement reactions where one drug increases the free concentration of another, potentially leading to toxicity (FDA, 2020). Consequently, while not a target for drug action, they are a critical consideration in drug design, dosing, and safety assessment, especially in populations with altered protein levels due to liver or kidney disease. Understanding these non-specific interactions is essential for predicting drug-drug interactions and ensuring therapeutic efficacy across diverse patient profiles.

Other names

Plasma proteinsBlood constituentsSerum proteinsErythrocytesBlood cellsCirculating proteins

Non-specific binding to plasma proteins or partitioning into blood cells, affecting the free fraction and distribution of drugs.